USB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
US Bancorp (USB) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has shown strong financial performance in Q1 2026, with steady revenue and net income growth, positive analyst sentiment, and hedge fund buying activity. While there are no immediate AI Stock Picker signals, the SwingMax signal from April 1 has resulted in a 5.16% price increase, indicating positive momentum. The technical indicators also suggest a bullish trend, making it a solid entry point for long-term investment.
The technical indicators for USB are bullish. The MACD histogram is positive at 0.475, indicating upward momentum. The RSI is neutral at 57.296, suggesting no overbought or oversold conditions. The moving averages are bullish, with SMA_5 > SMA_20 > SMA_200. Key support and resistance levels are at S1: 52.545 and R1: 56.484, with the current pre-market price of 55.51 nearing the resistance level.
Q1 2026 financials showed strong growth: Revenue increased by 3.12% YoY, Net Income increased by 14.85% YoY, and EPS grew by 14.56% YoY.
Hedge funds are buying, with a 128.97% increase in buying activity over the last quarter.
Analysts have raised price targets, with multiple firms maintaining Outperform or Buy ratings.
The SwingMax signal from April 1 has resulted in a 5.16% price increase.
Some analysts have lowered price targets due to increased EPS uncertainty and rising cost of equity.
The stock has a 30% chance of declining by -3.96% in the next week and -5.72% in the next month, based on candlestick pattern analysis.
US Bancorp reported strong Q1 2026 financial results. Revenue increased to $6.35 billion, up 3.12% YoY. Net income grew to $1.84 billion, a 14.85% YoY increase. EPS rose to $1.18, reflecting a 14.56% YoY growth. The company demonstrated positive operating leverage and steady growth driven by investments and synergies from the Union Bank acquisition.
Analyst sentiment is generally positive. RBC Capital, Oppenheimer, and Barclays raised their price targets to $61, $73, and $67, respectively, citing strong Q1 earnings and positive operating leverage. However, firms like UBS, JPMorgan, and Evercore ISI have lowered targets slightly, citing market volatility and increased macro risks. The consensus remains favorable, with most analysts maintaining Outperform or Buy ratings.
